Oura Health Oy (ŌURA)

Oura Health Oy is a Finnish health technology company recognized for its ŌURA smart rings, which track various physiological metrics. Founded in 2013, the company's mission is to make health a daily practice, empowering individuals to understand and control their health journey. Headquartered in Oulu, Finland, ŌURA also maintains offices in Helsinki, Finland, and San Francisco, United States.

ŌURA's primary product is the ŌURA Ring, with the latest iteration being the Oura Ring 5. This wearable device tracks over 50 health metrics, including sleep patterns, activity levels, heart rate, heart rate variability (HRV), body temperature, blood oxygen levels, and stress. The ring integrates with a companion smartphone app that provides personalized insights and guidance. ŌURA operates a dual-revenue model, combining hardware sales with a monthly subscription for premium app features. The company serves both individual consumers and enterprise clients, including partnerships with organizations like the NBA and the U.S. military.

Tom Hale serves as the Chief Executive Officer of ŌURA. The company confidentially filed for an initial public offering (IPO) in May 2026, signaling a potential transition to a publicly traded entity. In June 2026, ŌURA launched its Oura Ring 5, featuring a slimmer design, improved accuracy, and enhanced battery life. Recent notable developments include a partnership with LillyDirect to support individuals using GLP-1 therapies and signing England football legends Harry Kane and Declan Rice as global brand ambassadors. ŌURA is positioned as a leading innovator in the wearable health technology market, having been recognized for its contributions to personal wellness and data-driven health insights.